CMTM6
CKLF-like MARVEL transmembrane domain-containing protein 6
Also known as: CKLF6_HUMAN, CKLFSF6, FLJ20396
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NX76
- Gene
- CMTM6
- Ensembl
- ENSG00000091317
- Chromosome
- 3
- Canonical length
- 183 aa
- Protein class
- Predicted membrane proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
This gene belongs to the chemokine-like factor gene superfamily, a novel family that is similar to the chemokine and transmembrane 4 superfamilies. This gene is one of several chemokine-like factor genes located in a cluster on chromosome 3. This gene is widely expressed in many tissues, but the exact function of the encoded protein is unknown. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
183 residues, UniProt reviewed canonical sequence.
>Q9NX76|CMTM6
1 MENGAVYSPT TEEDPGPARG PRSGLAAYFF MGRLPLLRRV LKGLQLLLSL LAFICEEVVS
61 QCTLCGGLYF FEFVSCSAFL LSLLILIVYC TPFYERVDTT KVKSSDFYIT LGTGCVFLLA
121 SIIFVSTHDR TSAEIAAIVF GFIASFMFLL DFITMLYEKR QESQLRKPEN TTRAEALTEP
181 LNALocalizationUniProt · AlphaFold · HPA
Whether an antibody against CMTM6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.4
- Highest tissue expression
- 166 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 166 nTPM
- liver: 124 nTPM
- bone marrow: 92 nTPM
- urinary bladder: 74 nTPM
- tonsil: 73 nTPM
- placenta: 66 nTPM
Single-cell type
- neutrophils: 1,208 nCPM
- breast lactating cells: 1,034 nCPM
- neutrophil progenitors: 561 nCPM
- platelets: 555 nCPM
- cdc: 508 nCPM
- megakaryocytes: 488 nCPM
Immune cell
- neutrophil: 314 nTPM
- non-classical monocyte: 211 nTPM
- eosinophil: 208 nTPM
- basophil: 177 nTPM
- intermediate monocyte: 133 nTPM
- total PBMC: 108 nTPM
Brain region
- choroid plexus: 39 nTPM
- medulla oblongata: 18 nTPM
- white matter: 18 nTPM
- spinal cord: 18 nTPM
- thalamus: 16 nTPM
- hypothalamus: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0.43
- gnomAD missense Z
- 0.5
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CMTM6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CMTM6 as an antibody target. Whether an autoantibody or antibody against CMTM6 could matter depends on whether native CMTM6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CMTM6 is annotated at the cell surface, where native CMTM6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CMTM6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...